Search Prime Contracts

75N93024C00008

Definitive Contract

Overview

Government Description
TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.
Place of Performance
New York, NY 10005 United States
Pricing
Cost No Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
14
Analysis Notes
Subcontracting Plan This Definitive Contract has an Individual Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
The Global Alliance For Tb Drug Development was awarded Definitive Contract 75N93024C00008 (75N930-24-C-00008) for To Develop A Novel Modulator Targeting Proteostasis For The Treatment Of M. Tuberculosis. worth up to $9,851,406 by the National Institute of Allergy and Infectious Diseases in May 2024. The contract has a duration of 4 years and was awarded through solicitation 2023 NIAID Omnibus Broad Agency Announcement full & open with NAICS 541715 and PSC AN12 via direct negotiation acquisition procedures with 18 bids received. As of today, the Definitive Contract has a total reported backlog of $7,375,783.

Status
(Open)

Last Modified 5/9/24
Period of Performance
5/10/24
Start Date
11/9/25
Current End Date
4/30/28
Potential End Date
27.0% Complete

Obligations and Backlog
$2.5M
Total Obligated
$2.5M
Current Award
$9.9M
Potential Award
25% Funded
$0.0
Funded Backlog
$7.4M
Total Backlog

Award Hierarchy

Definitive Contract

75N93024C00008

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75N93024C00008

Opportunity Lifecycle

Procurement history for 75N93024C00008

People

Suggested agency contacts for 75N93024C00008

Competition

Number of Bidders
18
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Yes
Business Size Determination
Large Business
Awardee UEI
CA1RNRESAZU6
Awardee CAGE
52VM4
Agency Detail
Awarding Office
75N930 NATIONAL INSTITUTES OF HEALTH NIAID
Funding Office
75N930
Created By
hhsteosl
Last Modified By
hhsteosl
Approved By
hhsteosl

Legislative

Legislative Mandates
None Applicable
Performance District
NY-10
Senators
Kirsten Gillibrand
Charles Schumer
Representative
Dan Goldman
Modified: 5/9/24